ARLTS1, potential candidate gene in familial aggregation of hematological malignancies

Bull Cancer. 2017 Feb;104(2):123-127. doi: 10.1016/j.bulcan.2016.10.016. Epub 2016 Nov 17.

Abstract

Introduction: Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological malignancies and familial cancer context.

Methods: In this study, we sequence the ARLTS1 gene in 100 patients belonging to 88 independent Tunisian and French families.

Results: After gene sequencing, we report 8 genetic variations, most of which were previously reported in several cancer forms. The most common variants were W149X and C148R and were previously associated to B-cell chronic lymphocytic leukemia and to high-risk of familial breast cancer.

Conclusions: These results emphasize the fact that ARLTS1 gene mutations can be considered as a potential predisposing factor in familial hematological malignancies and other several cancer forms.

Keywords: ARLTS1; Familial hematological malignancy; Hémopathies malignes familiales; Solid tumors; Tumeurs solides.

MeSH terms

  • ADP-Ribosylation Factors / genetics*
  • Breast Neoplasms / genetics
  • Cohort Studies
  • Female
  • France
  • Genes, Tumor Suppressor*
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Hematologic Neoplasms / genetics*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Male
  • Tunisia

Substances

  • ADP-Ribosylation Factors
  • ARL11 protein, human